BMB’s new primer in its Bonevolent™ line of technology has been granted a patent in China
Press release: Biomedical Bonding's unique primer formulation to enable strong adhesion between difficult substrates such as wet bone and metals to its resin-based composite has been granted a patent in China. The primer is an important part of BMB’s Bonevolent™ technology that enables surgeons to do on-site customizable bone fracture fixations.Biomedical Bonding AB has secured an additional patent in China based on a unique primer formulation for use together with its resin-based composite technology directly on wet bone substrates or metal implants. The patent in China is an important